A novel functional role for MMSET in RNA processing based on the link between the REIIBP isoform and its interaction...

Area of Science:

• Molecular Biology
• Cancer Biology
• Genetics

Background:

• The chromosomal translocation t(4;14) is a poor prognostic factor in multiple myeloma (MM).
• This translocation deregulates MMSET (WHSC1/NSD2) expression, which encodes two major protein isoforms.
• The role of the shorter isoform, REIIBP, in MM pathology was previously unclear.

Purpose of the Study:

• To characterize the function of the REIIBP isoform in myeloma cells.
• To investigate the molecular interactions of REIIBP within the cellular environment.
• To explore the impact of REIIBP on RNA splicing and its implications for MM.

Main Methods:

• Protein interaction studies to identify REIIBP binding partners.
• Analysis of the SMN (survival of motor neuron) complex.
• RNA sequencing (RNA-seq) to assess global changes in RNA splicing patterns.
• Cellular assays to evaluate the effects on spliceosomal ribonucleic particle assembly.

Main Results:

• A novel interaction between REIIBP and components of the SMN complex was identified.
• REIIBP's interaction with the SMN complex directly affects spliceosomal ribonucleic particle assembly.
• RNA-seq analysis revealed that REIIBP significantly influences the RNA splicing patterns in myeloma cells.

Conclusions:

• REIIBP plays a critical role in regulating RNA splicing in multiple myeloma through its interaction with the SMN complex.
• This discovery provides new insights into the molecular mechanisms underlying MM.
• The REIIBP-SMN complex interaction represents a potential novel therapeutic target for multiple myeloma treatment.